Research & Development Market Research Reports & Industry Analysis
Bringing R&D costs and times down, therefore, means there are many opportunities to improve efficiencies, advance technological innovation, and economize and optimize. The pharmaceutical R&D category tracks both drug pipeline reports, competitive R&D strategies, and markets important and ancillary to the research efforts themselves, including activities in the biotech and sector that impinge upon the process.
Research & Development Industry Research & Market Reports
-
Laboratory Animal Models, 3D Cultures, and Organoids: Global Markets
... in the market. Markets are broken out globally and by geographic region. Additionally, all major animal models and applications are covered in detail. The current report will provide detailed exposure about this market. This report ... Read More
-
Biotechnology Product Manufacturing
... (all based in the US), as well as Bayer and Merck Group (both based in Germany), CSL (Australia), Novo Nordisk (Denmark), and the biotech research arms of major international pharmaceutical companies such as Sanofi (France). ... Read More
-
Metabolic Disorder Therapeutics Market, Opportunity, Growth Drivers, Industry Trend Analysis and Forecast, 2024-2032
... biotechnology companies to foster innovations. To cite an instance, in November 2023, Biolexis Therapeutics, Inc. secured $10 million in funding to advance its metabolic drug development. Rising collaborations between the industry players and academia are ... Read More
-
Biotechnology in the UK - Industry Market Research Report
... Biotechnology industry is fast becoming a prominent part of the UK life science sector, alongside pharmaceutical and medical technology companies. The convergence of these three technologies makes it increasingly difficult to identify the boundaries between ... Read More
-
AI in Clinical Trials Market by Trial Phase (Phase I, Phase II and Phase III), Target Therapeutic Area (Cardiovascular Disorders, CNS Disorders, Infectious Diseases, Metabolic Disorders, Oncological Disorders and Other Disorders), End-User (Pharmaceutical and Biotechnology Companies, and Other End-Users) and Key Geographical Regions (Asia-Pacific, Europe, Latin America, Middle East and North Africa, and North America): Industry Trends and Global Forecasts, Till 2035
... Companies, and Other End-Users) and Key Geographical Regions (Asia-Pacific, Europe, Latin America, Middle East and North Africa, and North America): Industry Trends and Global Forecasts, Till 2035 AI IN CLINICAL TRIALS MARKET: OVERVIEW As per ... Read More
-
Human Organoids Market by Product (Liver, Kidney, Pancreatic Models (2D, 3D)), Disease Area (Oncology, GI, Neurological Disorders), Application (Drug Toxicity, Personalized Medicine), End User (Pharma & Biotech Companies, CROs) - Global Forecast to 2029
... value of the human organoids market will increase from an estimated USD 1.19 billion in 2024 to USD 2.33 billion in 2029, at a CAGR of 14.4% through the forecast period. Advancement in funding for ... Read More
-
Biotech Business December 2024
... on biotechnology products and companies. It reports which universities offer licensing of biotechnology research, which companies have entered licensing agreements, as well as the financial health of biotechnology companies and their expected growth or decline. Read More
-
Peptone Market By Source of Peptone (Animal Peptone, Plant Peptone, Microbial Peptone, Mixed Peptone), By End User (Pharmaceutical and Biotech Industry, Research Institutions, Food and Beverage Industry, Others), By Application (Cell Culture, Fermentation, Food and Beverages, Others): Global Opportunity Analysis and Industry Forecast, 2024-2035
... Beverages, Others): Global Opportunity Analysis and Industry Forecast, 2024-2035 The peptone market was valued at $149.5 million in 2023 and is estimated to reach $240.9 million by 2035, exhibiting a CAGR of 4.2% from 2024 ... Read More
-
Organoids Market Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Type (Intestine, Liver, Stomach, Pancreas, Lung, Brain, Kidney, and Others), Application (Developmental Biology Disease, Pathology of Infectious Disease, Regenerative Medicine, Drug Toxicity & Efficacy Testing, Drug Discovery & Personalized Medicine, and Others), Source (Pluripotent Stem Cells and Organ Specific Adult Stem Cell), Offering [Instruments (Devices and Equipment), Consumables (Sensors and Others), and Services], Method (Micropatterned Plates, Ultralow Attachment Plates, Hanging Drop, Microdroplet or Emulsion, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
... of Infectious Disease, Regenerative Medicine, Drug Toxicity & Efficacy Testing, Drug Discovery & Personalized Medicine, and Others), Source (Pluripotent Stem Cells and Organ Specific Adult Stem Cell), Offering [Instruments (Devices and Equipment), Consumables (Sensors and ... Read More
-
Global Bioprocess Technology Market 2024-2028
... provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors. The report offers an up-to-date analysis regarding the current market scenario, the latest ... Read More
-
IPS Cell Derived Organoids Market Research Report Information by Type (Brain Organoids, Heart Organoids, Lung Organoids, Liver Organoids, Kidney Organoids, and Others), by Application (Drug Discovery and Development, Disease Modelling, and Regenerative Medicine), by End User (Pharmaceutical and Biotechnology Companies, Academic and Research Institutes, and Contract Research Organization), and by Region (North America, Europe, Asia-Pacific, and Rest of the World Industry Forecast till 2032
... User (Pharmaceutical and Biotechnology Companies, Academic and Research Institutes, and Contract Research Organization), and by Region (North America, Europe, Asia-Pacific, and Rest of the World Industry Forecast till 2032 The IPS Cell Derived Organoids Market ... Read More
-
Preclinical CRO Global Market Opportunities And Strategies To 2033
... Animal Model: Small Animal Model; Large Animal Model4) By Model System: In Vivo; In Vitro5) By End User: Biopharmaceutical Companies; Government And Academic Institutes; Medical Device CompaniesCovering: Charles River Laboratories International, Inc.; Thermo Fisher Scientific ... Read More
-
Global AMicrobial Enrichment Broth Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030
... in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period. The Global Info Research report includes an overview of the development of the ... Read More
-
Aseptic Filling Machine Market by Type of Compatible Primary Container (Vials, Syringes, Cartridges, Ampoules, Capsules, and Other Containers), Scale of Operation (Clinical and Commercial), System Throughput (Low, Medium and High), End-user (Pharma / Biotech Companies and Contract Manufacturing Organizations) and Key Geographical Regions (North America, Europe, Asia-Pacific and Rest of the World): Industry Trends and Global Forecasts, Till 2035
... and Contract Manufacturing Organizations) and Key Geographical Regions (North America, Europe, Asia-Pacific and Rest of the World): Industry Trends and Global Forecasts, Till 2035 ASEPTIC FILLING MACHINE MARKET: OVERVIEW As per Roots Analysis, the global ... Read More
-
Global Synthetic Biology Technology Industry Trends Analysis Report 2024, Forecast to 2032 (Broken Down by Type, End User, Regional Analysis, and Competitive Landscape)
... by conducting both qualitative and quantitative analysis of the market, sharing concrete numbers and thorough insights from different market segments. The quantitative analysis includes both historical and forecast data of various market segments, while the ... Read More
-
Synthetic Biology Market by Tools (Oligonucleotides, Enzymes, Synthetic Cells), Technology (Sequencing, Bioinformatics), Applications (Drug Discovery, Tissue Regeneration, Biofuel, Food, Agriculture, Consumer Care, Environmental) - Global Forecast to 2029
... to surpass USD 31.52 billion in 2029 from USD 12.33 billion in 2024, with a significant CAGR of 20.6%. The excessive demand for bio-based products is providing momentum to the market growth. Furthermore, rising investment ... Read More
-
Organoids and Spheroids Market
... cell culture and bioengineering, coupled with the rising demand for personalized medicine. The influx of technologies is enabling precise disease modeling, drug testing, and tailored treatment approaches for enhancing therapeutic efficacy and patient outcomes.With increasing ... Read More
-
Al in Pathology Market by Neural Network (GAN, CNN, RNN), Function (Diagnostic, Image Analysis, CDSS, Data Management, Analytics), Use Case (Drug Discovery, Clinical workflow), End User (Hospital, Labs, Pharma/Biotech), & Region - Global Forecast to 2029
... 2029 The global AI in Pathology market is expected to reach USD 169.8 million by 2029 from USD 82.8 million in 2024 at a high CAGR of 15.4% during the forecast period. AI in pathology ... Read More
-
Biotechnology
... of 8.4% over the analysis period 2023-2030. DNA Sequencing Market, one of the segments analyzed in the report, is expected to record a 8.6% CAGR and reach US$33.5 Billion by the end of the analysis ... Read More
-
Interferon
... of 2.7% over the analysis period 2023-2030. Interferon Beta, one of the segments analyzed in the report, is expected to record a 3.1% CAGR and reach US$4.6 Billion by the end of the analysis period. ... Read More
-
Bone Morphogenetic Proteins
... by 2030, growing at a CAGR of 2.4% over the analysis period 2023-2030. Recombinant human bone morphogenetic protein-2 (rhBMP-2), one of the segments analyzed in the report, is expected to record a 2.6% CAGR and ... Read More
-
The Global Market for Industrial Biomanufacturing 2025-2035
... pharmaceutical industries. Products are isolated from natural sources, such as blood, cultures of microbes, animal cells, or plant cells grown in specialized equipment or dedicated cultivation environments. The cells/tissues or enzymes used may be natural ... Read More
-
Recombinant DNA Technology
... by 2030, growing at a CAGR of 4.6% over the analysis period 2023-2030. Medical Recombinant DNA Technology, one of the segments analyzed in the report, is expected to record a 5.1% CAGR and reach US$70.4 ... Read More
-
Research Antibodies
... at a CAGR of 4.9% over the analysis period 2023-2030. Reagent, one of the segments analyzed in the report, is expected to record a 4.6% CAGR and reach US$4.8 Billion by the end of the ... Read More
-
In Vivo Contract Research Organization (CRO)
... the year 2023, is expected to reach US$7.1 Billion by 2030, growing at a CAGR of 7.0% over the analysis period 2023-2030. Smalll Molecules Modality, one of the segments analyzed in the report, is expected ... Read More
Research Assistance
